Abstract
Mutations in the K-ras gene are very common in lung tumours and are implicated in the development of lung cancer, but the timing of their occurrence remains poorly understood. We investigated K-ras mutations in cell samples microdissected by laser capture microscopy at multiple sites from lung tissue sections representing tumour tissue and matched histologically normal tissue obtained from 48 lung cancer patients. K-ras mutations were detected in cell samples from 10 of 38 (26.3%) lung adenocarcinomas and in none of the histologically normal or tumour cell samples taken from 10 lung squamous cell carcinomas. Of the K-ras mutation-positive adenocarcinomas, in 4 cases a mutation was found in only the tumour tissue, in 1 case a mutation was found only in the histologically normal tissue, and in 5 cases mutations were found in both the tumour tissue and histologically normal tissue. Among these 5 cases, 2 had identical mutations in both the tumour tissue and histologically normal tissue, 2 had 1 mutation in the tumour tissue and 2 mutations in the histologically normal tissue, 1 of which was identical to the mutation found in the tumour, and 1 case had 2 codon 12 mutations in tumour tissue and 2 mutations, in codons 9 and 11, in histologically normal tissue. These results showed that K-ras mutations are frequent in histologically normal cells taken from outside lung adenocarcinomas and suggest that some of these mutations may represent early events which could pave the way of lung carcinogenesis. © 2001 Cancer Research Campaign www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
American Cancer Society (2000) Cancer Facts and Figures – 2000. American Cancer Society,
Barbacid M (1987) ras genes. Annu Rev Biochem 56: 779–827
Berthelemy P, Bouisson M, Escourrou J, Vaysse N, Rumeau JL and Pradayrol L (1995) Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer. Ann Intern Med 123: 188–191
Bishop JM (1991) Molecular themes in oncogenes. Cell 64: 235–248
Brentnall TA, Chen R, Lee JG, Kimmey MB, Bronner MP, Haggitt RC, Kowdley KV, Hecker LM and Byrd DR (1995) Microsatellite instability and K-ras mutations associated with pancreatic adenocarcinoma and pancreatitis. Cancer Res 55: 4264–4267
Clements NC, Nelson MA, Wymer JA, Savage C, Aguirre M and Garewal H (1995) Analysis of K-ras gene mutations in malignant and nonmalignant endobronchial tissue obtained by fiberoptic bronchoscopy. Am J Respir Crit Care Med 152: 1374–1378
Der CJ, Finkel T and Cooper GM (1986) Biological and Biochemical properties of humanrasHgenes mutated at codon 61. Cell 44: 167–176
Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, Weiss RA and Liotta LA (1996) Laser capture microdissection. Science 274: 998–1001
Gazdar AF (1994) The molecular basis of human lung cancer. Anticancer Res 13: 261–268
Harris CC (1991) Chemical and physical carcinogenesis: advances and perspectives. Cancer Res 51: 5023s–5044s
Hollstein M, Sidransky D, Vogelstein B and Harris CC (1991) p53 mutations in human cancers. Science 253: 49–53
Husgafvel-Pursiainen K, Hackman P, Ridanpaa M, Anttila S, Karjalainen A, Partanen T, Taikina-Aho O, Heikkila L and Vaino H (1993) K-ras mutations in human adenocarcinoma of the lung: association with smoking and exposure to asbestos. Int J Cancer 53: 250–256
Keohavong P, DeMichele MAA, Melacrinos AC, Landreneau RJ, Weyant RJ and Siegfried JM (1996) Detection of K-ras mutations in lung carcinomas: Relationship to prognosis. Clin Cancer Res 2: 411–418
Keohavong P, Zhu D, Melacrinos AC, DeMichele MAA, Weyant RJ, Luketich JD, Testa JR, Fedder M and Siegfried JM (1997a) Detection of low-fraction K-ras mutations in primary lung tumors using sensitive methods. Int J Cancer 74: 162–170
Keohavong P, Zhu D, Whiteside TL, Swalsky P, Bakker A, Elder EM, Siegfried JM, Srivastava S and Finkelstein SD (1997b) Detection of infrequent and multiple K-ras mutations in human tumors and tumor-adjacent tissues. Anal Biochem 247: 394–403
Khosravi-Far R and Der CJ (1994) The ras signal transduction pathway. Cancer Metast Rev 13: 67–89
Li ZH, Zheng J, Weiss LM and Shibata D (1994) c-K-rasand p53 mutations occur very early in adenocarcinoma of the lung. Am J Pathol 144: 303–309
Marshall CJ (1991) Tumor suppressor genes. Cell 64: 313–326
Mills NE, Fishman CL, Rom WN, Dubin N and Jacobson DR (1995) Increased prevalence of K-rasoncogene mutations in lung adenocarcinoma. Cancer Res 55: 1444–1447
Minamoto T, Yamashita N, Ochiai A, Mai M, Sugimura T, Ronai Z and Esumi H (1995) Mutant K-rasin apparently normal mucosa of colorectal cancer patients: its potential as a biomarker of colorectal tumorigenesis. Cancer 75: 1520–1526
Minna JD, Pass H, Glatstein E and Ihde DC (1989) Lung cancer. Principles and Practice of Oncology, de Vita VT, Rosenberg S, Hellman S (eds). pp. 591–705, Lippincott JB: Philadelphia
Pretlow TP, Barrow BJ, Ashton WS, O’Riordan MA, Pretlow TG, Jurcisek JA and Stellato TA (1991) Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res 51: 1564–1567
Rodenhuis S and Slebos RJ (1992) Clinical significance ofrasoncogene activation in human lung cancer. Cancer Res 52: 2665s–2669s
Rosell R, Monzo M, Pifarre A, Ariza A, Sanchez JJ, Moreno I, Maurel J, Lopez M, Abad A and de Anta JM (1996) Molecular staging of non-small cell lung cancer according to K-rasgenotypes. Clin Cancer Res 2: 1083–1086
Santos E, Martin-Zanca D, Reddy EP, Pierotti MA, Della Porta G and Barbacid M (1984) Malignant activation of a K-rasoncogene in lung carcinoma but not in normal tissue of the same patient. Science 223: 661–664
Seeburgh PH, Colby WW, Capon DJ, Goeddel DV and Levinson AD (1984) Biological properties of human c-H-rasgenes mutated at codon 12. Nature 312: 71–75
Slaughter TP, Southwick HW and Smejkel W (1953) Field cancerization in oral stratified epithelium. Cancer 6: 963–968
Sozzi G, Miozzo M, Pastorino U, Pilotti S, Donghi R, Giarola M, Gregorio LD, Manenti G, Radice P, Minoletti F, Porta GD and Pierotti MA (1995) Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesion. Cancer Res 55: 135–140
Stanley LA (1995) Molecular aspects of chemical carcinogenesis: the roles of oncogenes and tumor suppressor genes. Toxicology 96: 173–194
Strong MS, Incze J and Vaughan CW (1984) Field cancerization in the aerodigestive tract – its etiology, manifestation, and significance. J Ontolaryn 13: 1–6
Sugio K, Ishida T, Yokoyama H, Inoue T, Sugimachi K and Sasazuki T (1992) rasgene mutation as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis. Cancer Res 52: 2903–2906
Sugio K, Kishimoto Y, Virmani AK, Hung JY and Gazdar AF (1994) K-ras mutations are relatively late event in the pathogenesis of lung carcinomas. Cancer Res 54: 5811–5815
Suzuki Y, Orita M, Shiraishi M, Hayashi K and Sekiya T (1990) Detection ofrasgene mutations in human lung cancer by single-stranded conformational polymorphism analysis of polymerase chain reaction products. Oncogene 5: 1037–1043
Tada M, Ohashi M, Shiratori Y, Okudaira T, Komatsu Y, Kawabe T, Yoshida H, Machinami R, Kishi K and Omata M (1996) Analysis of K-rasgene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology 110: 227–231
Urban T, Ricci S, Lacave R, Antoine M, Kambouchner M, Capron F and Bernaudin JF (1996) Codon 12 Ki-rasmutation in non-small-cell lung cancer: comparative evaluation in tumoural and non-tumoural lung. Brit J Cancer 74: 1051–1055
Urban T, Ricci S, Danel C, Antoine M, Kambouchner M, Godard V, Lacave R and Bernaudin JF (2000) Detection of codon 12 K-ras mutations in non-neoplastic mucosa from bronchial carina in patients with lung cancer. Brit J cancer 82: 412–417
Westra WH, Slebos RJ, Offerhaus GJ, Goodman SN, Evers SG, Kensler TW, Askin FB, Rodenhius S and Hruban RH (1993) K-rasoncogene activation in lung adenocarcinomas from former smokers. Cancer 72: 432–438
Westra WH, Baas IO, Hruban RH, Askin FB, Wilson K, Offenhaus GJA and Slebos RJC (1996) K-rasoncogene activation in atypical alveolar hyperplasia of the human lung. Cancer Res 56: 2224–2228
Wilentz RE, Chung CH, Sturm PD, Musler A, Sohn TA, Offerhaus GJ, Yeo CJ, Hruban RH and Slebos RJ (1998) K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma. Cancer 82: 96–103
Yakubovskaya MS, Spiegelman V, Luo FC, Malaev F, Salnew A, Zborovskaya I, Gasparian A, Polotsky B, Machaladze Z, Trachtenberg AC, Belitsky GA and Ronai Z (1995) High frequency of K-ras mutations in normal appearing lung tissues and sputum of patients with lung cancer. Int J Cancer 63: 810–814
Yanagisawa A, Ohtake K, Ohashi K, Hori M, Kitagawa T, Sugano H and Kato Y (1993) Frequent c-Ki-rasoncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res 53: 953–956
Zhu D, Keohavong P, Finkelstein SD, Swalska P, Bakker A, Weissfeld J, Srivastava S and Whiteside TL (1997) K-ras mutations in normal colorectal tissues from K-rasmutation-positive colorectal cancer patients. Cancer Res 57: 2485–2492
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Keohavong, P., Mady, H., Gao, W. et al. Topographic analysis of K-ras mutations in histologically normal lung tissues and tumours of lung cancer patients. Br J Cancer 85, 235–241 (2001). https://doi.org/10.1054/bjoc.2001.1913
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.1913